Comcapsy 400 mg/20 mg Tablet is a combination of anticancer medicine containing Capecitabine and Cyclophosphamide are active ingredients. Comcapsy 400 mg/20 mg Tablet is used in the treatment of metastatic breast cancer in patients who did not respond adequately to other anticancer medicines, (breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, or lungs.). It is important to note that while metastatic breast cancer cannot be cured, it can be managed and the progression of the disease can be slowed.
Comcapsy 400 mg/20 mg Tablet is not recommended for use in children and adolescents less than 18 years of age, because safety and efficacy have not been clinically established.
Comcapsy 400 mg/20 mg Tablet may cause some common side effects like hair loss, joint pain, dizziness, fatigue, headache, cough, weight loss, neutropenia (decreased white blood cell count), etc. It is important to report any side effects to your doctor.
It's important before taking Benefits of Comcapsy 400 mg/20 mg Tablet to inform your doctor, if you have any pre-existing disease or if you are using any medications or vitamins. Herbal medicines, etc. Additionally, inform them if you are pregnant, planning to become pregnant, or breastfeeding.
Comcapsy 400 mg/20 mg Tablet may take with or without food. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Metastatic breast cancer (advanced-stage breast cancer): Comcapsy 400 mg/20 mg Tablet used in the treatment of metastatic breast cancer (is a type of breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, or lungs.).
Comcapsy 400 mg/20 mg Tablet can help to slow or kills the growth of cancer cells. Comcapsy 400 mg/20 mg Tablet can help to decrease the size of tumours and may even lead to the complete remission of cancer.
Comcapsy 400 mg/20 mg Tablet is not a cure for breast cancer. However, Comcapsy 400 mg/20 mg Tablet can help to slow the progression of the disease and improve the quality of life for people with breast cancer.
Comcapsy 400 mg/20 mg is a combination of medicine that has been shown to be effective in treating various types of cancer. Comcapsy 400 mg/20 mg Tablet is particularly useful in cases where other chemotherapy regimens have not been successful.
Comcapsy 400 mg/20 mg Tablet may have fewer side effects compared to other chemotherapy drugs. Comcapsy 400 mg/20 mg Tablet can make treatment more tolerable for patients.
Comcapsy 400 mg/20 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Comcapsy 400 mg/20 mg Tablet may take with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Comcapsy 400 mg/20 mg Tablet containing capecitabine and cyclophosphamide are active ingredients. Capecitabine works by inhibiting the synthesis of DNA, which is necessary for the proliferation and survival of cancer cells. Cyclophosphamide works by works by inhibiting the synthesis of DNA and RNA, which are necessary for the growth and division of cancer cells. This combination of medicine kills cancer cells more effectively.
Comcapsy 400 mg/20 mg Tablet is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Comcapsy 400 mg/20 mg such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
It is generally not recommended to drink alcohol while taking Comcapsy 400 mg/20 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
patients with kidney disease should closely monitor kidney function while taking Comcapsy 400 mg/20 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Comcapsy 400 mg/20 mg Tablet should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
It is not recommended to breastfeed while taking Comcapsy 400 mg/20 mg Tablet. Comcapsy 400 mg/20 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Comcapsy 400 mg/20 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
Comcapsy 400 mg/20 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Comcapsy 400 mg/20 mg Tablet and report any unusual symptoms or changes in liver function to their doctor. The dose of Comcapsy 400 mg/20 mg may need to be adjusted in patients with liver disease.
Use of Comcapsy 400 mg/20 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Comcapsy 400 mg/20 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
1. Xeloda, (capecitabine) Tablets, For Oral Use , Genentech, Usa. Inc, Product Leaflet
2. Xeloda, Capecitabine Tablets, Hoffmann-la Roche Limited. [last Revised Apr-04-2022 ], Product Monograph
3. Dosage Of Capecitabine And Cyclophosphamide Combination Therapy In Patients With Metastatic Breast Cancer, National Library Of Medicine, Available From
4. Fixed-Dose Combination Of Capecitabine And Cyclophosphamide In Metastatic Breast Cancer: Results From The Enclose Phase 2/3 Randomized Multicenter Study, Author-Sudeep Gupta, Available Form